Asset Details
Do you wish to reserve the book?
The Drug-Dosing Conundrum in Oncology — When Less Is More
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Drug-Dosing Conundrum in Oncology — When Less Is More
Do you wish to request the book?
The Drug-Dosing Conundrum in Oncology — When Less Is More
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Drug-Dosing Conundrum in Oncology — When Less Is More
2021
Overview
Doses and schedules of oncology drugs are sometimes inadequately characterized before registration trials. The “more is better” paradigm is still used for dose selection, despite the recognition that targeted therapies require alternative approaches to dose optimization.
Publisher
Massachusetts Medical Society
Subject
